| abstract |
Described herein are compounds of Formula I that modulate the activity of TNAP. In some embodiments, the compounds of Formula I described herein inhibit TNAP. In certain embodiments, the compounds of Formula I described herein are useful in the treatment of conditions associated with hyper-mineralization. (see above formula) |